EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP

Remyelination in the adult brain relies on the reactivation of the Neuronal Precursor Cell (NPC) niche and differentiation into Oligodendrocyte Precursor Cells (OPCs) as well as on OPC maturation into myelinating oligodendrocytes (OLs). These two distinct phases in OL development are defined by tran...

Full description

Bibliographic Details
Main Authors: Emanuela Nocita, Alice Del Giovane, Marta Tiberi, Laura Boccuni, Denise Fiorelli, Carola Sposato, Elena Romano, Francesco Basoli, Marcella Trombetta, Alberto Rainer, Enrico Traversa, Antonella Ragnini-Wilson
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/8/844
_version_ 1827846560294109184
author Emanuela Nocita
Alice Del Giovane
Marta Tiberi
Laura Boccuni
Denise Fiorelli
Carola Sposato
Elena Romano
Francesco Basoli
Marcella Trombetta
Alberto Rainer
Enrico Traversa
Antonella Ragnini-Wilson
author_facet Emanuela Nocita
Alice Del Giovane
Marta Tiberi
Laura Boccuni
Denise Fiorelli
Carola Sposato
Elena Romano
Francesco Basoli
Marcella Trombetta
Alberto Rainer
Enrico Traversa
Antonella Ragnini-Wilson
author_sort Emanuela Nocita
collection DOAJ
description Remyelination in the adult brain relies on the reactivation of the Neuronal Precursor Cell (NPC) niche and differentiation into Oligodendrocyte Precursor Cells (OPCs) as well as on OPC maturation into myelinating oligodendrocytes (OLs). These two distinct phases in OL development are defined by transcriptional and morphological changes. How this differentiation program is controlled remains unclear. We used two drugs that stimulate myelin basic protein (MBP) expression (Clobetasol and Gefitinib) alone or combined with epidermal growth factor receptor (EGFR) or Retinoid X Receptor gamma (RXRγ) gene silencing to decode the receptor signaling required for OPC differentiation in myelinating OLs. Electrospun polystyrene (PS) microfibers were used as synthetic axons to study drug efficacy on fiber engagement. We show that EGFR inhibition per se stimulates MBP expression and increases Clobetasol efficacy in OPC differentiation. Consistent with this, Clobetasol and Gefitinib co-treatment, by co-regulating RXRγ, MBP and phosphatidylinositol 4,5-bisphosphate (PIP2) levels, maximizes synthetic axon engagement. Conversely, RXRγ gene silencing reduces the ability of the drugs to promote MBP expression. This work provides a view of how EGFR/ErbB inhibition controls OPC differentiation and indicates the combination of Clobetasol and Gefitinib as a potent remyelination-enhancing treatment.
first_indexed 2024-03-12T09:17:43Z
format Article
id doaj.art-24fd526a1c554a4ba46163efbaae0ba7
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T09:17:43Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-24fd526a1c554a4ba46163efbaae0ba72023-09-02T14:42:23ZengMDPI AGCells2073-44092019-08-018884410.3390/cells8080844cells8080844EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBPEmanuela Nocita0Alice Del Giovane1Marta Tiberi2Laura Boccuni3Denise Fiorelli4Carola Sposato5Elena Romano6Francesco Basoli7Marcella Trombetta8Alberto Rainer9Enrico Traversa10Antonella Ragnini-Wilson11NeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyAdvanced Microscopy Center, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyDepartment of Engineering, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartment of Engineering, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartment of Engineering, Università Campus Bio-Medico di Roma, 00128 Rome, ItalySchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 611731, ChinaNeurotechIT Laboratory, Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, ItalyRemyelination in the adult brain relies on the reactivation of the Neuronal Precursor Cell (NPC) niche and differentiation into Oligodendrocyte Precursor Cells (OPCs) as well as on OPC maturation into myelinating oligodendrocytes (OLs). These two distinct phases in OL development are defined by transcriptional and morphological changes. How this differentiation program is controlled remains unclear. We used two drugs that stimulate myelin basic protein (MBP) expression (Clobetasol and Gefitinib) alone or combined with epidermal growth factor receptor (EGFR) or Retinoid X Receptor gamma (RXRγ) gene silencing to decode the receptor signaling required for OPC differentiation in myelinating OLs. Electrospun polystyrene (PS) microfibers were used as synthetic axons to study drug efficacy on fiber engagement. We show that EGFR inhibition per se stimulates MBP expression and increases Clobetasol efficacy in OPC differentiation. Consistent with this, Clobetasol and Gefitinib co-treatment, by co-regulating RXRγ, MBP and phosphatidylinositol 4,5-bisphosphate (PIP2) levels, maximizes synthetic axon engagement. Conversely, RXRγ gene silencing reduces the ability of the drugs to promote MBP expression. This work provides a view of how EGFR/ErbB inhibition controls OPC differentiation and indicates the combination of Clobetasol and Gefitinib as a potent remyelination-enhancing treatment.https://www.mdpi.com/2073-4409/8/8/844remyelinationEGFR inhibitorsmoothened agonistmicrofibersdrug screening
spellingShingle Emanuela Nocita
Alice Del Giovane
Marta Tiberi
Laura Boccuni
Denise Fiorelli
Carola Sposato
Elena Romano
Francesco Basoli
Marcella Trombetta
Alberto Rainer
Enrico Traversa
Antonella Ragnini-Wilson
EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
Cells
remyelination
EGFR inhibitor
smoothened agonist
microfibers
drug screening
title EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
title_full EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
title_fullStr EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
title_full_unstemmed EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
title_short EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP
title_sort egfr erbb inhibition promotes opc maturation up to axon engagement by co regulating pip2 and mbp
topic remyelination
EGFR inhibitor
smoothened agonist
microfibers
drug screening
url https://www.mdpi.com/2073-4409/8/8/844
work_keys_str_mv AT emanuelanocita egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT alicedelgiovane egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT martatiberi egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT lauraboccuni egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT denisefiorelli egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT carolasposato egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT elenaromano egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT francescobasoli egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT marcellatrombetta egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT albertorainer egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT enricotraversa egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp
AT antonellaragniniwilson egfrerbbinhibitionpromotesopcmaturationuptoaxonengagementbycoregulatingpip2andmbp